TIDES Europe: Oligonucleotide and Peptide Therapeutics 2023

The industry’s leading event in Europe to accelerate therapeutics to market by expediting R&D, improving CMC efficiency and building new partnerships

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market, with an emphasis on the European region.

Visionary speakers across the entire landscape of oligonucleotides, peptides, mRNA and more!

Here are the confirmed speakers for 2023:

Paul Nioi, PhD
Vice President, Discovery and Translational Research
Alnylam Pharmaceuticals

Knud Jensen, PhD
Professor, Department of Chemistry
University of Copenhagen

Sotirios Tsimikas, M.D.
Senior Vice President of Global Cardiovascular Development
Ionis Pharmaceuticals

Alfred Von Krempelhuber
Medical Director
Moderna Germany GmbH

Beatriz De La Torre, Ph.D.
Research Professor, Laboratory of Medicine and Med
University Of KwaZulu-Natal

Markus Muttenthaler
Associate Professor, Neuropeptide Research
The University of Queensland and University of Vienna

Jill Caswell, PhD
Biology Team Leader
Almac Sciences

Key areas of focus

The TIDES Europe 2022 hybrid program features 3 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Oligonucleotide Chemistry, Manufacturing & Controls
Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical
Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical
Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing
Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Macromolecular Drug Delivery
Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing